 Connection
Shannon Kasperbauer to Mycobacterium abscessus
This is a "connection" page, showing publications Shannon Kasperbauer has written about Mycobacterium abscessus.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.352 |
|
|
|
-
Nick JA, Martiniano SL, Lovell VK, Vestal B, Poch K, Caceres SM, Rysavy NM, de Moura VC, Gilick JJ, Malcolm KC, Pacheco J, Amin AG, Chatterjee D, Daley CL, Kasperbauer S, Gross JE, Armantrout E, Cohen KA, Keck A, Vandalfsen JM, Magaret AS, Midamba N, Chapdu C, Gao A, Hill JE, Freeman KG, Cristinziano M, Guerrero C, Jacobs-Sera D, Lauer MJ, Viland M, Hatfull GF. Trial design of bacteriophage therapy for nontuberculous mycobacteria pulmonary disease in cystic fibrosis: The POSTSTAMP study. J Cyst Fibros. 2025 Jul; 24(4):684-690.
Score: 0.205
-
Dousa KM, Kurz SG, Taracila MA, Bonfield T, Bethel CR, Barnes MD, Selvaraju S, Abdelhamed AM, Kreiswirth BN, Boom WH, Kasperbauer SH, Daley CL, Bonomo RA. Insights into the l,d-Transpeptidases and d,d-Carboxypeptidase of Mycobacterium abscessus: Ceftaroline, Imipenem, and Novel Diazabicyclooctane Inhibitors. Antimicrob Agents Chemother. 2020 07 22; 64(8).
Score: 0.147
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|